Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Sales | 16,928 | 27,253 | 26,847 | 25,837 | 17,010 |
| Cost of Goods | 11,698 | 16,000 | 16,804 | 18,427 | 12,022 |
| Gross Profit | 5,230 | 11,253 | 10,043 | 7,410 | 4,988 |
| Operating Expenses | 3,785 | 3,571 | 4,412 | 3,706 | 3,177 |
| Operating Income | 2,143 | 7,682 | 6,435 | 4,131 | 1,833 |
| Interest Expense | 211 | 524 | 342 | 405 | 395 |
| Other Income | 158 | 69 | -244 | -72 | 576 |
| Pre-tax Income | 2,090 | 7,227 | 5,849 | 3,654 | 2,014 |
| Income Tax | 917 | 3,228 | 2,646 | 1,632 | 871 |
| Net Income Continuous | 1,173 | 3,999 | 3,203 | 2,022 | 1,143 |
| Net Income | $1,173 | $3,999 | $3,203 | $2,022 | $1,143 |
| EPS Basic Total Ops | 0.23 | 0.82 | 0.65 | 0.41 | 0.23 |
| EPS Basic Continuous Ops | 0.23 | 0.82 | 0.65 | 0.41 | 0.23 |
| EPS Diluted Total Ops | 0.23 | 0.81 | 0.65 | 0.41 | 0.23 |
| EPS Diluted Continuous Ops | 0.23 | 0.80 | 0.65 | 0.41 | 0.23 |
| EBITDA(a) | $2,578 | $8,614 | $6,999 | $4,443 | $2,250 |